Octane Biotech Inc.
Records under this name other than the patents Octane Biotech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.
Showing 1 to 7 of 7 · Back to Octane Biotech Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,499,780 | Advanced tissue engineering system Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,546,142 | Reverse flow perfusion of three-dimensional scaffolds Lapsed on the fee record Ended Oct 1, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 1, 2025 | USPTO record |
| US 8,492,140 | Automated tissue engineering system Term ended Term ended Jun 7, 2025 · USPTO record | Term ended | Term ended Jun 7, 2025 | USPTO record |
| US 9,534,195 | Automated tissue engineering system Formerly held Term ended Term ended Aug 5, 2024 · USPTO record | Term ended | Term ended Aug 5, 2024 | USPTO record |
| US 10,723,986 | Automated tissue engineering system Formerly held Term ended Term ended May 30, 2024 · USPTO record | Term ended | Term ended May 30, 2024 | USPTO record |
| US 9,701,932 | Automated tissue engineering system Formerly held Term ended Ended no later than Apr 8, 2023 · USPTO record | Term ended | Ended no later than Apr 8, 2023 | USPTO record |
| US 10,844,338 | Automated tissue engineering system Term ended Term ended Apr 8, 2023 · USPTO record | Term ended | Term ended Apr 8, 2023 | USPTO record |